The purpose of this study is to evaluate the systemic exposure and pharmacodynamics of two doses of nebulized fluticasone/formoterol combination as compared to the monocomponents.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
97
inhalation suspension
inhalation suspension
inhalation solution
Investigative Site
San Diego, California, United States
Investigative Site
Panama City, Florida, United States
Investigative Site
Madisonville, Kentucky, United States
Plasma AUC(0-t) after 1 week of dosing
Time frame: PK sampling over 24 hrs
FEV1
Time frame: pre-dose and 2 hrs post-dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Investigative Site
Sunset, Louisiana, United States
Investigative Site
Charlotte, North Carolina, United States
Investigative Site
Medford, Oregon, United States
Investigative Site
Greenville, South Carolina, United States
Investigative Site
Spartanburg, South Carolina, United States
Investigative Site
Union, South Carolina, United States
Investigative Site
San Antonio, Texas, United States
...and 2 more locations